Read the full article here.
This content was originally published by McKinsey Insights & Publications. Original publishers retain all rights. It appears here for a limited time before automated archiving. By McKinsey Insights & Publications
Significant increases in incidence rates have made cancer a high priority in China. Progress has resulted from innovative treatments and greater access to care, yet much more needs to be done.